Financings in Brief: Cardiac Science, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science, Inc.: Completes $1.5 mil. private placement. Proceeds are tabbed for gearing up manufacturing of the firm's Powerheart automatic external cardioverter defibrillator for initial sales in "selected European countries," Cardiac Science states. In conjunction with the offering, administered by Sorbus Asset Strategies S.A., a one-for-11.43 reverse stock split was effected Sept. 8 to reduce shares outstanding to about 5.9 mil...